MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-WB-10-0069540
Kemecos India Pvt Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.35 Cr
▲ 4% YoY
Net profit · FY 2025
₹92.86 Lakh
Net margin 3.8%
EBITDA · FY 2025
₹2.45 Cr
EBITDA margin 10.1%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹52.25 Lakh
Issued & subscribed
Open charges
₹13.3 Cr
Secured borrowings
Company age
31 yrs
Est. 1995
Employees · EPFO
43
Provident fund records
About Kemecos India Pvt Ltd
Data last updated:
Kemecos India Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 June 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1995PTC072263. Its GSTIN is 19AABCK2527N1Z9 (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹52.25 Lakh. It is led by directors including Sankar Dasgupta and Jaidipa Dasgupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 126 B Chatterjee Roadp S Kasba, Kolkata, West Bengal, India – 700042.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.35 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹92.86 Lakh (net margin 3.8%) and EBITDA of ₹2.45 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 8% over five years.
The company has about 43 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹13.3 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹35.4 Lakh; the latest was in March 2014. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Carewell Steuart Pharma Private Limited with revenue of ₹24.5 Cr.
Kemecos India Pvt Ltd is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-WB-10-0069540). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kemecosindia.com.
Company details
CIN U24239WB1995PTC072263
Registration Number 072263
Incorporation Date 21 June 1995
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-WB-10-0069540
Recognitions & Rankings of Kemecos India
Contact details
Kemecos India Pvt Ltd's registered office is in Kolkata, West Bengal. Its website is kemecosindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address126 B Chatterjee Roadp S Kasba, Kolkata, West Bengal, India – 700042
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kemecos India Pvt Ltd, buy the company report.
Comprehensive company report
Kemecos India Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kemecos India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kemecos India Pvt Ltd, buy the company report.
Financials of Kemecos India Pvt Ltd
FY 2025 filings availableKemecos India Pvt Ltd reported revenue of ₹24.35 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹24.35 Cr ▲ 4%
Net profit · FY 2025
₹92.86 Lakh margin 3.8%
EBITDA · FY 2025
₹2.45 Cr margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 1%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 5%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 4% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kemecos India Pvt Ltd, buy the company report.
Board of directors of Kemecos India Pvt Ltd
Kemecos India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sankar Dasgupta | Director | 21 Jun 1995 | 31 Years 4 Months | Current |
| Jaidipa Dasgupta | Director | 06 Feb 2020 | 6 Years 8 Months | Current |
| Tapash Ghosh | Director | 21 Jun 1995 | 31 Years 4 Months | Current |
Peer comparison
Kemecos India Pvt Ltd is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India | |||
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | 92.0% | Chennai, Tamil Nadu, India | |||
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Kemecos India Pvt Ltdthis company | ₹24.35 Cr (FY 2025) | ₹92.86 Lakh | 3.8% | 4.0% | 43 | Kolkata, West Bengal, India |
| Aeon Formulations Private Limited | ₹24.33 Cr (FY 2025) | -16.0% | Chennai, Tamil Nadu, India | |||
| Axacus Pharma Private Limited | ₹24.29 Cr (FY 2024) | 37.0% | Ahmedabad, Gujarat, India | |||
| Chemifine Formulations Private Limited | ₹24.25 Cr (FY 2024) | -10.0% | Nellore, Andhra Pradesh, India |
To see the full peer comparison of Kemecos India Pvt Ltd, buy the company report.
Auditor
Kemecos India Pvt Ltd is audited by NARAYAN K. AGRAWAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NARAYAN K. AGRAWAL & CO. | FY 2023 | 006336C |
Shareholding
The shareholding of Kemecos India Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kemecos India Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹13.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2024 | 100871419 | Others | ₹1.5 Cr | Open | |
| 06 Jun 2005 | 90247550 | Others | ₹11.8 Cr | Open |
To see the full charge records of Kemecos India Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Kemecos India Pvt Ltd has 2 deals on record (2 funding rounds), with disclosed funding of ₹35.4 Lakh; the latest was in March 2014.
Total deals
2
Funding rounds
2
Disclosed funding
₹35.4 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Funding round | ₹25 Lakh | Investors: 4 individuals |
| Mar 2013 | Funding round | ₹10.4 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kemecos India Pvt Ltd has 4 court cases on record: 4 filed by Kemecos India. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| District courts | 1 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Writ petition | Filed by the company against Uttar Pradesh Medical Supplies Corporation Limited and Anr | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against M/S Sahil Chem and Pharma | Pending |
| Calcutta High Court | Writ petition | Filed by the company against Uttar Pradesh Medicial Supplies Corporation Limited and Ors. and 2 others | Disposed |
| Allahabad High Court | Court case (A482) | Filed by the company against State of U.P. and Another | Disposed |
To see the full case history of Kemecos India Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kemecos India Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kemecos India Pvt Ltd has a workforce of 43 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
43
Active EPFO establishments
1
Employee growth
16.22%
GST
Kemecos India has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCK2527N1Z9 | West Bengal | Active | 01 Jul 2017 |
| 18AABCK2527N1ZB | Assam | Active | 01 Aug 2017 |
To see the full GST registrations and return filing status of Kemecos India Pvt Ltd, buy the company report.
Recent activity
Kemecos India Pvt Ltd has 5 board changes on record since 1995: 3 appointments and 2 cessations. The latest: Jaidipa Dasgupta ceased to be Additional Director on 31 Dec 2020.
AGM
Kemecos India Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 1.50 Cr registered on 05 Feb 2024 with Charge ID 100871419 was modified on 13 May 2025.
Filing
Kemecos India Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100871419 was registered on 05 Feb 2024.
Charges
A charge with Others of Rs. 11.80 Cr registered on 06 Jun 2005 with Charge ID 90247550 was modified on 05 Feb 2024.
Ceased
Jaidipa Dasgupta ceased to be Additional Director.
Appointed
Jaidipa Dasgupta was appointed as Director.
Ceased
Santibrata Dasgupta ceased to be Director.
Charges
A charge with Others amounted to Rs. 11.80 Cr with Charge ID 90247550 was registered on 06 Jun 2005.
Appointed
Sankar Dasgupta was appointed as Director.
Appointed
Tapash Ghosh was appointed as Director.
Incorporation
21 Jun 1995
Kemecos India Pvt Ltd was registered on 21 Jun 1995 with Roc Kolkata & aged 31 years 4 months as per MCA records.
Frequently asked questions
Kemecos India is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 June 1995 (31+ years old) and is registered under CIN U24239WB1995PTC072263.
Kemecos India has 3 current directors:
- Sankar Dasgupta - Director
- Jaidipa Dasgupta - Director
- Tapash Ghosh - Director
The latest financial statements of Kemecos India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kemecos India is 19AABCK2527N1Z9, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 18AABCK2527N1ZB (Assam).
The CIN (Corporate Identification Number) of Kemecos India is U24239WB1995PTC072263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kemecos India has 4 court cases on record: 4 filed by the company. 1 is pending. Most are in the high courts.
Kemecos India was incorporated on 21 June 1995, making it 31+ years old. It is registered with the Registrar of Companies, Kolkata.
Kemecos India has 2 deals on record (2 funding rounds), with disclosed funding of ₹35.4 Lakh; the latest was in March 2014.
The peers of Kemecos India by revenue are Carewell Steuart Pharma Private Limited, MRHM Pharma Private Limited, Sunberg Life Sciences Private Limited, Axon Drugs Private Limited, Aeon Formulations Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jaidipa Dasgupta ceased to be Additional Director on 31 Dec 2020. Jaidipa Dasgupta was appointed as Director on 06 Feb 2020. Santibrata Dasgupta ceased to be Director on 10 Jan 2020. Kemecos India has 5 board changes on record in total.
Yes, Kemecos India is registered as an MSME under Udyam registration (number: UDYAM-WB-10-0069540).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages